Hugin

Results: 641



#Item
81

Hawesko Holding AG Hamburg ISIN DE0006042708 Reuters HAWG.DE, Bloomberg HAW GR Neun-Monats-Bericht zum 30. September 2004

Add to Reading List

Source URL: hugin.info

Language: German - Date: 2006-01-17 17:02:06
    82

    Hawesko Holding AG Hamburg ISIN DE0006042708 Reuters HAWG.DE, Bloomberg HAW GR Drei-Monats-Bericht zum 31. März 2006

    Add to Reading List

    Source URL: hugin.info

    Language: German - Date: 2006-05-04 03:53:04
      83

      06_DE Halbjahresfinanzbericht.pdf

      Add to Reading List

      Source URL: hugin.info

      Language: German - Date: 2014-08-06 01:20:12
        84

        Geschäftsberichtfinanzkalender Geschäftsbericht 19. juni 2006 . . . . . . . . . . . . . . . Hauptversammlung in Hamburg/letzter Tag vor Ex-Dividende-Notierung

        Add to Reading List

        Source URL: hugin.info

        Language: German - Date: 2006-06-09 05:39:17
          85

          Hawesko Holding AG Hamburg ISIN DE0006042708 Reuters HAWG.DE, Bloomberg HAW GR Drei-Monats-Bericht zum 31. März 2005

          Add to Reading List

          Source URL: hugin.info

          Language: German - Date: 2006-01-17 17:02:08
            86

            Hawesko Holding AG Hamburg ISIN DE0006042708 Reuters HAWG.DE, Bloomberg HAW GR Sechs-Monats-Bericht zum 30. Juni 2009

            Add to Reading List

            Source URL: hugin.info

            Language: German - Date: 2009-07-29 01:40:13
              87

              INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL Conformément aux dispositions de l’articledu règlement général de l’Autorité des marchés financiers, Fimalac

              Add to Reading List

              Source URL: hugin.info

              - Date: 2015-08-05 09:22:12
                88

                FRONTLINE LTD. SECOND QUARTER AND SIX MONTHS 2015 RESULTS Highlights   

                Add to Reading List

                Source URL: hugin.info

                Language: English - Date: 2015-08-26 01:42:27
                  89

                  REGULATED INFORMATION ABLYNX ANNOUNCES HALF-YEAR RESULTS FOR 2015  Caplacizumab on track to enter Phase III in acquired TTP, with Ablynx committed to lead commercialisation in Europe and the USA  4 Phase II clinic

                  Add to Reading List

                  Source URL: hugin.info

                  Language: English - Date: 2015-08-26 11:07:31
                    90

                    Q2 2015 Results ’ August 26, 2015

                    Add to Reading List

                    Source URL: hugin.info

                    Language: English - Date: 2015-09-03 09:21:40
                      UPDATE